Abstention from filtered coffee may reduce heart disease risk factors

August 23, 2001

Elevated serum concentrations of homocysteine (tHcy) and cholesterol are associated with increased risk of ischemic heart disease (IHD). Previous studies found that consumption of large amounts of unfiltered coffee resulted in increases in serum tHcy and cholesterol, suggesting a specific effect related to brewing methods. In a new study in the American Journal of Clinical Nutrition, Christensen et al. studied a group of healthy nonsmoking volunteers, 47% of whom drank filtered caffeinated coffee an average of 4.9 cups per day. Cholesterol and tHcy levels went down in those subjects who abstained from filtered coffee, indicating that refraining from commonly consumed amounts of coffee could contribute to a long-term reduction in IHD risk.

One-hundred-eighty-three Norwegian men and women, aged 24-69 years, were randomly assigned to 3 groups and instructed to either abstain from coffee, drink 1-3 cups daily, or ≥4 cups daily. After 6 weeks, abstention from coffee resulted in decreases in total cholesterol and tHcy, as well as a significant increase in levels of the B vitamin folate. Because folate is an important determinant of serum tHcy concentrations, the rise in folate concentrations may have been the cause of the decline in tHcy. Total cholesterol, tHcy, and serum folate concentrations were unchanged in both groups of coffee drinkers. Extrapolating these results to long-term risk for IHD, abstaining from 4 cups/day of coffee would reduce cholesterol-related risk of IHD by 15% and tHcy-related risk of IHD by 10%.

The authors conclude that relative elevations of tHcy and cholesterol are caused by compounds such as terpenoids, which are only partially removed from coffee in the filtering process.
-end-
Christensen, Benedicte, et al. Abstention from filtered coffee reduces the concentrations of plasma homocysteine and serum cholesterol--a randomized controlled trial. Am J Clin Nutr 2001;74:302-7

This media release is provided by The American Society for Clinical Nutrition to provide current information on nutrition-related research. This information should not be construed as medical advice. If you have a medical concern, consult your doctor. To see the complete text of this article, please go to:

http://faseb.org/ajcn/September/12043-Christensen.pdf

For more information, please contact: benedicte.christensen@ioks.uio.no

American Journal of Clinical Nutrition

Related Cholesterol Articles from Brightsurf:

Cholesterol's effects on cellular membranes
The findings have far-reaching implications in the general understanding of disease, the design of drug delivery methods, and many other biological applications that require specific assumptions about the role of cholesterol in cell membranes.

Autism-cholesterol link
Study identifies genetic link between cholesterol alterations and autism.

Microbes might manage your cholesterol
Researchers discover a link between human blood cholesterol levels and a gene in the microbiome that could one day help people manage their cholesterol through diet, probiotics, or entirely new types of treatment.

Experimental cholesterol-lowering drug effective at lowering bad cholesterol, study shows
Twice-yearly injections of an experimental cholesterol-lowering drug, inclisiran, were effective at reducing low-density lipoprotein (LDL) cholesterol, often called bad cholesterol, in patients already taking the maximum dose of statin drugs, according to data of the ORION-10 trial presented Saturday, Nov.

Rethinking how cholesterol is integrated into cells
Cholesterol is best known in connection with cardiovascular disease, but cholesterol is also vital for many fundamental processes in the body.

Seed oils are best for LDL cholesterol
Using a statistical technique called network meta-analysis, researchers have combined the results of dozens of studies of dietary oils to identify those with the best effect on patients' LDL cholesterol and other blood lipids.

Cholesterol leash: Key tethering protein found to transport cellular cholesterol
Cholesterol is an essential component of living organisms, but the mechanisms that transport cholesterol inside the cell are poorly understood.

New way to treat cholesterol may be on the horizon
A breakthrough discovery by scientists at Houston Methodist Research Institute could change the way we treat cholesterol.

How low should LDL cholesterol go?
New analysis shows that in a high-risk population, achieving ultra-low LDL cholesterol levels, down to <10 mg/dL, safely results in additional lowering of risk of cardiovascular events.

Does boosting 'good' cholesterol really improve your health?
A new review addresses the mysteries behind 'good' HDL cholesterol and why boosting its levels does not necessarily provide protection from cardiovascular risk for patients.

Read More: Cholesterol News and Cholesterol Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.